CAS: 138847-85-5 - PRE-084
Fórmula:C19H27NO3
InChI:InChI=1S/C19H27NO3/c21-18(23-16-13-20-11-14-22-15-12-20)19(9-5-2-6-10-19)17-7-3-1-4-8-17/h1,3-4,7-8H,2,5-6,9-16H2
Chave InChI:InChIKey=RQHKZUBCUZVZEF-UHFFFAOYSA-N
SMILES:O=C(OCCN1CCOCC1)C2(C=3C=CC=CC3)CCCCC2
- Sinónimos:
- 2-(4-Morpholinethyl) 1-Phenylcyclohexanecarboxylate Hydrochloride
- 2-(4-Morpholinethyl)-1-Phenylcyclohexanecarboxylate Hcl
- 2-(4-Morpholino)Ethyl-1-Phenylcyclohexane-1-Carboxylate
- 2-(4-Morpholinyl)ethyl 1-phenylcyclohexanecarboxylate
- 2-(Morpholin-4-Yl)Ethyl 1-Phenylcyclohexanecarboxylate
- 2-Morpholinoethyl 1-phenylcyclohexanecarboxylate
- Cyclohexanecarboxylic acid, 1-phenyl-, 2-(4-morpholinyl)ethyl ester
- PRE-084HCl
- Pre-084 Hydrochloride
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Cyclohexanecarboxylic acid, 1-phenyl-, 2-(4-morpholinyl)ethyl ester REF: IN-DA0019P9CAS: 138847-85-5 | 98% | A consultar | Sex 29 Nov 24 | |
Pre-084 REF: TM-T3198CAS: 138847-85-5 | 99.91% | A consultar | Qui 05 Dez 24 | |
PRE-084 hydrochloride REF: 3D-NFA84785CAS: 138847-85-5 | Min. 95% | A consultar | Qui 09 Jan 25 |
Cyclohexanecarboxylic acid, 1-phenyl-, 2-(4-morpholinyl)ethyl ester
CAS:138847-85-5
Fórmula:
C19H27NO3
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
317.4226
Ref: IN-DA0019P9
10mg | A consultar |
Entrega estimada em Estados Unidos, Sexta-feira 29 de Novembro de 2024
Pre-084
CAS:138847-85-5
Pre-084 is a high affinity, selective σ1 agonist.
Fórmula:
C19H28ClNO3
Pureza:
99.91%
Cor e Forma:
Solid
Peso molecular:
353.88
Ref: TM-T3198
10mg | 469,00 € | ||
50mg | 1.878,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 5 de Dezembro de 2024
PRE-084 hydrochloride
Produto ControladoCAS:138847-85-5
PRE-084 hydrochloride is a compound that binds to the dopamine transporter (DAT), inhibiting uptake of …
Fórmula:
C19H27NO3·HCl
Pureza:
Min. 95%
Peso molecular:
353.89 g/mol
Ref: 3D-NFA84785
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 9 de Janeiro de 2025